January may have been slow in terms of M&A news, but Boston was ablaze with new funding last month.
A couple of startups raised monster funding rounds. Indigo Ag kicked us off with a $200 million round, consisting of $175 million in convertible equity and $25 million in debt. Wakefield-based cannabis operator Curaleaf announced the upsizing and closing of a senior secured term loan facility from a syndicate of lenders totaling $300 million.
Over in the biotech world, Generation Bio, a Cambridge-based gene therapy company, closed a $110 million Series C financing. And in one of the largest-ever Series A rounds, a new Cambridge startup, EQRx, raised $200 million to upend the drug industry’s approach to pricing.
Healthtech company Concerto HealthAI, which provides data and enterprise AI technology solutions for precision oncology, raised $150 million in Series B financing. Lexington-based Berkshire Grey, the SoftBank-backed robotics company, raised $263 million to fund global expansions, acquisitions and hiring.
On top of all that, four local investment firms raised a total of $3.75 billion for new investments.Read Complete Article